Concurrent chemoradiotherapy with paclitaxel and nedaplatin followed by consolidation chemotherapy in locally advanced squamous cell carcinoma of the uterine cervix: Preliminary results of a phase II study

International Journal of Radiation Oncology Biology Physics

Volumn 78, Issue 3, 2010, Pages 821-827

  Zhang, Mei Qin ^a   Liu, Su Ping ^b   Wang, Xiang E ^b  

^a FUDAN UNIVERSITY   (China)

^b NONE

Author keywords

Cervical carcinoma; Concurrent chemoradiotherapy; Consolidation chemotherapy; Nedaplatin; Paclitaxel

Indexed keywords

4-CYCLE; BRACHYTHERAPY; CERVICAL CARCINOMA; COMPLETE RESPONSE; CONCURRENT CHEMORADIOTHERAPY; CONCURRENT CHEMOTHERAPY; DISTANT METASTASIS; EXTERNAL BEAM RADIOTHERAPY; FOLLOW UP; HIGH DOSE RATE; NEDAPLATIN; OVERALL SURVIVAL; PACLITAXEL; PHASE II; PROGRESSION FREE SURVIVAL; RANDOMIZED TRIAL; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX;

RADIOTHERAPY; TOXICITY;

CHEMOTHERAPY;

ERYTHROPOIETIN; GRANULOCYTE COLONY STIMULATING FACTOR; NEDAPLATIN; ONDANSETRON; PACLITAXEL; ANTINEOPLASTIC AGENT; PLATINUM COMPLEX;

ADULT; ANEMIA; ARTICLE; BRACHYTHERAPY; CANCER CHEMOTHERAPY; CLINICAL TRIAL; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HUMAN; LEUKOPENIA; LIVER FUNCTION; MAJOR CLINICAL STUDY; METASTASIS; NAUSEA; NEUROPATHY; NEUTROPENIA; OVERALL SURVIVAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RADIATION DOSE; SIDE EFFECT; SKIN TOXICITY; SQUAMOUS CELL CARCINOMA; THROMBOCYTOPENIA; TREATMENT FAILURE; UTERINE CERVIX CARCINOMA; VOMITING; CANCER STAGING; CARCINOMA, SQUAMOUS CELL; DISEASE FREE SURVIVAL; DRUG ADMINISTRATION; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PROCEDURES; REMISSION; UTERINE CERVICAL NEOPLASMS;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; LEUKOPENIA; MIDDLE AGED; NEOPLASM STAGING; NEUTROPENIA; ORGANOPLATINUM COMPOUNDS; PACLITAXEL; RADIOTHERAPY; REMISSION INDUCTION; UTERINE CERVICAL NEOPLASMS;

EID: 77957202523     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2009.08.069     Document Type: Article

References (29)

1. D.M. Parkin, F. Bray, and J. Ferlay Global cancer statistics, 2002 CA Cancer J Clin 55 2005 74 108
2. C.W. Whitney, W. Sause, and B.N. Bundy A randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stages IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: A Gynecologic Oncology Group and Southwest Oncology Group study J Clin Oncol 17 1999 1339 1348
3. P.G. Rose, B.N. Bundy, and E.B. Watkins Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer N Engl J Med 340 1999 1144 1153
4. H.M. Keys, B.N. Bundy, and F.B. Stehman Cisplatin, radiation and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma N Engl J Med 340 1999 1154 1161
5. M. Morris, P.J. Eifel, and J. Lu Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high risk cervical cancer N Engl J Med 340 1999 1137 1143
6. J.A. Green, J.M. Kirwan, and J.F. Tierney Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: A systematic review and meta-analysis Lancet 358 2001 781 786
7. H. Lucca, H. Hirte, and A. Fyles Concurrent cisplatin-based chemotherapy plus radiotherapy for cervical cancer: A meta-analysis Clin Oncol 14 2002 203 212
8. Chemoradiotherapy for Cervical Cancer Meta-Analysis Collaboration Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: A systematic review and meta-analysis of individual patient data from 18 randomized trials J Clin Oncol 26 2008 5802 5811
9. P.J. Eifel, K. Winter, and M. Morris Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: An update of radiation therapy oncology group trial (RTOG) 90-01 J Clin Oncol 22 2004 872 880 (Pubitemid 41103599)
10. W.P. McGuire, J.A. Blessing, and D.H. Moore Paclitaxel has moderate activity in squamous cervix cancer. A Gynecologic Oncology Group study J Clin Oncol 14 1996 792 795
11. M. Rodriguez, B.U. Sevin, and J. Perras Paclitaxel: A radiation sensitizer of human cervical cancer cells Gynecol Oncol 57 1995 165 169
12. T. Kato, H. Nishimura, and M. Yakushiji Phase II study of 254-S (cis-diammine glycolato platinum) for gynecological cancer Gan to Kagaku Ryoho 19 1992 695 701
13. M. Follen, C.F. Levenback, and R.B. Iyer Imaging in cervical cancer Cancer 98 2003 2028 2038
14. H.J. Choi, J.W. Roh, and S.S. Seo Comparison of the accuracy of magnetic resonance imaging and positron emission tomography/computed tomography in the presurgical detection of lymph node metastases in patients with uterine cervical carcinoma: a prospective study Cancer 106 2006 914 922
15. F. Girardi, E. Petru, and M. Heydarfadai Pelvic lymphadenectomy in the surgical treatment of endometrial cancer Gynecol Oncol 49 1993 177 180
16. A. Ayhan, Z.S. Tuncer, and R. Tuncer Tumor status of lymph nodes in early endometrial cancer in relation to lymph need size Eur J Obstet Gynecol Biol 60 1995 61 63
17. T. Thigpen, R.T. Vance, and T. Kansur The platinum compounds and paclitaxel in the management of carcinoma of the endometrium and the uterine cervix Semin Oncol 22 Suppl12 1995 67 72
18. J.T. Hartmann, and H.P. Lipp Toxicity of platinum compounds Expert Opin Pharmacother 4 2003 889 901
19. Y. Hasegawa, S. Takanashi, and K. Okudera Weekly paclitaxel and nedaplatin with concurrent radiotherapy for locally advanced non-small-cell lung cancer: A phase I/II study Jpn J Clin Oncol 34 2004 647 653
20. B. Emami, J. Lyman, and A. Brown Tolerance of normal tissue to therapeutic irradiation Int J Radiat Oncol Biol Phys 21 1991 109 122
21. C.H. Choi, J.W. Lee, and T.J. Kim Phase II study of consolidation chemotherapy after concurrent chemoradiation in cervical cancer: Preliminary results Int J Radiat Oncol Biol Phys 68 2007 817 822
22. F. Flueckiger, F. Ebner, and H. Poschauko Cervical cancer: Serial MR imaging before and after primary radiation therapy - A 2-year follow-up study Radiology 184 1992 89 93
23. K. Hatano, Y. Sekiya, and H. Araki Evaluation of the therapeutic effect of radiotherapy on cervical cancer using magnetic resonance imaging Int J Radiat Oncol Biol Phys 45 1999 639 644
24. M.L. Berman, H. Keys, and W. Creasman Survival and patterns of recurrence in cervical cancer metastatic to periaortic lymph nodes (a Gynecologic Oncology Group study) Gynecol Oncol 19 1984 8 16
25. L.C. Wong, H.Y. Ngan, and A.N. Cheung Chemoradiation and adjuvant chemotherapy in cervical cancer J Clin Oncol 17 1999 2055 2060
26. E. Vrdoljak, T. Prskalo, and T. Omrcen Concomitant chemobrachyradiotherapy with ifosfamide and cisplatin followed by consolidation chemotherapy in locally advanced squamous cell carcinoma of the uterine cervix: Results of a phase II study Int J Radiat Oncol Biol Phys 61 2005 824 829 (Pubitemid 40247978)
27. V. Lorvidhaya, I. Chitapanarux, and S. Sangruchi Concurrent mitomycin C, 5-Fluorouracil, and radiotherapy in the treatment of locally advanced carcinoma of the cervix: A randomized trial Int J Radiat Oncol Biol Phys 55 2003 1226 1232
28. M.Y. Lee, H.G. Wu, and K. Kim Concurrent radiotherapy with paclitaxel/carboplatin chemotherapy as a definitive treatment for squamous cell carcinoma of the uterine cervix Gynecol Oncol 104 2007 95 99
29. S. Spensley, R.D. Hunter, and J.E. Livsey Clinical outcome for chemoradiotherapy in carcinoma of the cervix Clin Oncol 21 2009 49 55